U.S. flag

An official website of the United States government

NM_000516.7(GNAS):c.30G>A (p.Glu10=) AND GNAS-related disorder

Germline classification:
Likely benign (1 submission)
Last evaluated:
Jan 25, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004534439.2

Allele description [Variation Report for NM_000516.7(GNAS):c.30G>A (p.Glu10=)]

NM_000516.7(GNAS):c.30G>A (p.Glu10=)

Gene:
GNAS:GNAS complex locus [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20q13.32
Genomic location:
Preferred name:
NM_000516.7(GNAS):c.30G>A (p.Glu10=)
HGVS:
  • NC_000020.11:g.58891756G>A
  • NG_016194.2:g.57017G>A
  • NM_000516.7:c.30G>AMANE SELECT
  • NM_001077488.5:c.30G>A
  • NM_001077489.4:c.30G>A
  • NM_001077490.3:c.*1-3856G>A
  • NM_001309840.2:c.-39+2403G>A
  • NM_001309842.2:c.30G>A
  • NM_001309861.2:c.-38-3856G>A
  • NM_001309883.1:c.*159-3856G>A
  • NM_001410912.1:c.44-3856G>A
  • NM_001410913.1:c.2069-3856G>A
  • NM_016592.5:c.*43-3856G>A
  • NM_080425.4:c.2069-3856G>A
  • NM_080426.4:c.30G>A
  • NP_000507.1:p.Glu10=
  • NP_001070956.1:p.Glu10=
  • NP_001070957.1:p.Glu10=
  • NP_001296771.1:p.Glu10=
  • NP_536351.1:p.Glu10=
  • NC_000020.10:g.57466811G>A
  • NM_000516.5:c.30G>A
Molecular consequence:
  • NM_001077490.3:c.*1-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001309840.2:c.-39+2403G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001309861.2:c.-38-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001309883.1:c.*159-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001410912.1:c.44-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001410913.1:c.2069-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_016592.5:c.*43-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_080425.4:c.2069-3856G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000516.7:c.30G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001077488.5:c.30G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001077489.4:c.30G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001309842.2:c.30G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_080426.4:c.30G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
GNAS-related disorder
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004712118PreventionGenetics, part of Exact Sciences
no assertion criteria provided
Likely benign
(Jan 25, 2021) 		germlineclinical testing

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004712118.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024